New tuberculosis vaccine results presented at FAPESP Week China (IMAGE)
Caption
Researchers from the Butantan Institute and collaborators reveal why recombinant BCG induces a stronger and longer-lasting response than the conventional vaccine.
Credit
Karina Toledo
Usage Restrictions
No
License
Original content